@realroseceline Hard to disagree with all you said, but refuting emerging competitive treats (over last 5y or so) is how you build conviction in this case.
$LPK is up >100% since my initial thesis:
Glass substrates are a massive supply chain bottleneck for CPO / advanced packaging.
$LPK has a quasi monopoly over equipment supply with >80% of major global players choosing their equipment for process validation.
Order volumes are set to inflect later this year.
With peak adoption coming in 2027 w/ companies like $INTC + Samsung focus more capacity there.
When all of this ramp-up starts filtering into the P&L in 2027, we'll see more institutions/retail piling in.
Especially since balance sheet is v. clean which means very minimal dilution risk along the way.
My napkin maths get the MC to ~€2B+ in 2027 via volume ramp + CPO TAM expansion. (Including some uncertainty over order values).
So still very early imo.
@rhomboid1MF@dopamine_uptake Stephen is a much better CEO than Mike Creedon (& fun fact: Mike Creedon is « open to work » on LinkedIn since 2y). Stephen might look somewhat akward when presenting. But he is actually smart, focused on acquiring good businesses and create SHL value which is all that matters.
@MoodyWriter13 That’s positive - is the chairman of the Stiftung playing an important role? They seem conservative according to historical cash allocation (no acquisition, no SBB, deleveraging to net cash position ex-pension). Do they see their job as creating value for shareholders?
@fedex774 [Genuinely love debating ideas] - what is your valuation framework? I see $MEMS.PA at a similar valuation than Nynomic for example (20x EBIT range), with accelerating AI-exposed business.